Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.

Published in:

Oncologist, 2018, v. 23, n. 2, p. 193, doi. 10.1634/theoncologist.2017-0413

By:

• Sartor, Oliver;
• Vogelzang, Nicholas J.;
• Sweeney, Christopher;
• Fernandez, Daniel C.;
• Almeida, Fabio;
• Iagaru, Andrei;
• Brown Jr., Alan;
• Smith, Matthew R.;
• Agrawal, Manish;
• Dicker, Adam P.;
• Garcia, Jorge A.;
• Lutzky, Jose;
• Wong, Yu‐Ning;
• Petrenciuc, Oana;
• Gratt, Jeremy;
• Shore, Neal D.;
• Morris, Michael J.;
• for the U.S. Expanded Access Program Investigators

Publication type:

Article